Source comparison
Best Tesamorelin Supplier: Quality Comparison
The table below compares the key differentiators that define supplier quality for research-grade Tesamorelin. These are not marketing features. They're the technical checkpoints that determine whether your peptide performs as a GHRH analog. Synthesis Method Sm
This comparison does not assign a generated winner or score.
- The table below compares the key differentiators that define supplier quality for research-grade Tesamorelin. These are not marketing features. They're the technical checkpoints that determine whether your peptide performs as a GHRH analog.
- Synthesis Method
- Small-batch SPPS with Fmoc chemistry, >99.5% coupling efficiency per step, preparative HPLC purification
- Large-batch synthesis, undisclosed coupling efficiency, minimal post-synthesis purification
- Coupling efficiency below 99% compounds across 44 steps, producing heterogeneous mixtures unsuitable for dose-response studies
- Purity Verification
- Third-party reverse-phase HPLC (≥98% main peak) + ESI-MS molecular weight confirmation + amino-acid analysis
- In-house UV absorbance estimate or generic "certificate of purity" without chromatogram
- Without independent chromatography, "98% pure" is an unverifiable claim. Deletion sequences and oxidized residues go undetected
- Batch Documentation
- Lot-specific HPLC chromatogram, mass spectrum, peptide content (mg active peptide), synthesis date, expiration based on stability data
- Net weight only, no analytical data, vague storage instructions
- Lack of peptide content reporting forces guesswork on molar concentration calculations, introducing systematic dosing error
- Stability Data
- Lyophilized stability at -20°C (24–36 months), reconstituted stability at 2–8°C (28 days with <12% degradation), referenced testing
- No stability information provided, or generic "store frozen" guidance without timeframes
- Stability data is essential for planning multi-week studies and understanding when reconstituted peptide loses potency
- Endotoxin Testing
- LAL assay on every batch, <1.0 EU/mg reported on CoA
- Not tested or not disclosed
- Endotoxin contamination introduces inflammatory confounders in cell and animal studies, invalidating results
- Traceability & Support
- Full synthesis records retained per batch, technical support for protocol troubleshooting
- Batch records not accessible, no post-sale support
- When experimental results are inconsistent, access to synthesis logs allows investigation of peptide quality as a variable